Unnecessary Data Transcription Steps Prevalent in Early Drug Discovery Outsourcing Projects

There is an overwhelming use of officeefficiency programs to present project data; the current status quo is for service providers to pull data out of their systems and prepare progress reports to present to clients. This process is time-consuming and requires constant touchpoints to keep everyone up-to-date. And while the prepared project-update reports may be easy to view, they are not easy to use. Such reports are stagnant and leave the underlying data inaccessible for secondary use. The data cannot be easily uploaded into a client’s databases. They cannot be easily passed into specialty software for secondary analyses or use in machinelearning or AI tools. They can’t easily be collated with other datasets to attain broader insights. They are not easy to find or use again in the future.

Interestingly, despite acknowledging the strong need for data-management solutions, neither bio companies nor service providers were well versed with the options available on the market to help deliver positive change.